Pages that link to "Q33374851"
Jump to navigation
Jump to search
The following pages link to Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders (Q33374851):
Displaying 50 items.
- Knockdown of ZNF268, which is transcriptionally downregulated by GATA-1, promotes proliferation of K562 cells (Q24301614) (← links)
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen (Q24306795) (← links)
- Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity (Q24307490) (← links)
- The progress of early growth response factor 1 and leukemia (Q26748151) (← links)
- How animal models of leukaemias have already benefited patients (Q26997702) (← links)
- Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice (Q28114815) (← links)
- Therapy-related myeloid neoplasms: pathobiology and clinical characteristics (Q28386366) (← links)
- CDK6 as a key regulator of hematopoietic and leukemic stem cell activation (Q28587749) (← links)
- T-cells null for the MED23 subunit of mediator express decreased levels of KLF2 and inefficiently populate the peripheral lymphoid organs (Q28593879) (← links)
- The role of lenalidomide in the management of myelodysplasia with del 5q. (Q33378398) (← links)
- Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis (Q33412120) (← links)
- SRF is required for neutrophil migration in response to inflammation (Q33585299) (← links)
- Pituitary gland development and disease: from stem cell to hormone production (Q33687947) (← links)
- Formins in development: orchestrating body plan origami (Q33729427) (← links)
- Ribosomopathies: human disorders of ribosome dysfunction (Q33806050) (← links)
- The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS. (Q33839824) (← links)
- Haploinsufficient tumor suppressor genes (Q33864922) (← links)
- Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies (Q33896721) (← links)
- Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS. (Q33987086) (← links)
- The EGR family gene egrh-1 functions non-autonomously in the control of oocyte meiotic maturation and ovulation in C. elegans (Q34080650) (← links)
- Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. (Q34348631) (← links)
- The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disorders (Q34358020) (← links)
- MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia (Q34386922) (← links)
- Regression analysis of combined gene expression regulation in acute myeloid leukemia (Q34393824) (← links)
- Ribosomopathies: mechanisms of disease (Q34454066) (← links)
- Egr1 mediates p53-independent c-Myc–induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism (Q34490491) (← links)
- Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice (Q34707445) (← links)
- Genetic pathways leading to therapy-related myeloid neoplasms (Q35039992) (← links)
- Chromosome 5q deletion is extremely rare in patients with myelofibrosis (Q35535523) (← links)
- Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML (Q35651714) (← links)
- Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling (Q35803662) (← links)
- Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q). (Q36064278) (← links)
- Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1). (Q36247578) (← links)
- Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells (Q36274044) (← links)
- Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. (Q36274109) (← links)
- Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease (Q37002112) (← links)
- Therapy-related myeloid leukemia. (Q37009760) (← links)
- pH modulates the binding of early growth response protein 1 transcription factor to DNA (Q37028241) (← links)
- Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip (Q37038586) (← links)
- Genetics of therapy-related myelodysplasia and acute myeloid leukemia (Q37058777) (← links)
- MLL5 contributes to hematopoietic stem cell fitness and homeostasis (Q37100715) (← links)
- Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia (Q37140487) (← links)
- A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide (Q37293324) (← links)
- Loss of quiescence and impaired function of CD34(+)/CD38(low) cells one year following autologous stem cell transplantation (Q37377939) (← links)
- Genome wide molecular analysis of minimally differentiated acute myeloid leukemia (Q37406787) (← links)
- Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer (Q37423777) (← links)
- Therapy-related myeloid neoplasms (Q37428433) (← links)
- Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc. (Q37464115) (← links)
- Enthalpic factors override the polyelectrolyte effect in the binding of EGR1 transcription factor to DNA. (Q37497572) (← links)
- 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. (Q37549908) (← links)